Curaleaf Stock Skyrockets: The Market Rally You Can’t Ignore

Curaleaf just pulled off a market stunner—sending shockwaves through trading floors and lighting up portfolios. Here's why the cannabis giant's shares are burning up the charts.

The Spark That Lit the Fire

No fluff, no filler—just pure momentum. Curaleaf's surge wasn't luck; it was a calculated play in a sector hungry for wins.

Wall Street's Love-Hate Tango

Analysts scrambled to adjust targets while skeptics muttered about 'overvalued green rush dreams.' Same old dance, just a faster tempo.

What’s Next? Hold or Fold?

Volatility’s the name of the game. Whether this rally has legs or becomes another 'buy the rumor, sell the news' cliché depends on who’s holding the bag. Classic finance—where hope and hype collide.

A new push for rescheduling

President TRUMP is currently mulling a proposal to, on the federal level, reclassify marijuana as a less harmful drug -- at least, he said so in a press briefing on Monday. Meanwhile, on Wednesday, a Republican congressman quadrupled down on a legislative effort to get that job done.

Image source: Getty Images.

Greg Steube of Florida filed a bill he's sponsoring, the "Marijuana 1-to-3 Act," for the fourth session in a row. The name references the "schedules" used by the Drug Enforcement Agency, from 1 (for the most harmful drugs with minimal medical value) to 5 (least harmful). The proposed rescheduling of pot WOULD knock it down from 1 to 3 within 60 days of the bill's passing, effectively legalizing it.

Steube has been an advocate for reform for years. In 2019, he said that if the restrictions on marijuana are loosened, "the opportunities for research and study are drastically expanded."

Legalize it, say Americans

Leaning toward legalization is a clever stance for a politician to take, as there is very broad public support for reform of the federal government's harsh, rigid stance on the drug. According to a 2024 survey conducted by Gallup and cited by PBS News, support for legalization has risen dramatically, to 68% last year from 36% in 2005.